Crohn's Disease and Colitis Trial, Recruiting NCT07385807 Sponsor: University of British Columbia Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Crohn's Disease and Colitis Trial, Recruiting

NCT07385807
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Pregnant people aged 19 or older who are recruited during their first, second, or early third trimester of pregnancy
  • People who own or regularly have access to a smartphone that works with an app called RXFood
  • For the IBD group: people who have a confirmed diagnosis of Crohn's disease or ulcerative colitis, whether their disease is currently active or settled
  • For the non-IBD comparison group: people who do not have inflammatory bowel disease (IBD)

Who may not be able to join:

  • People who are unable to give informed consent to participate
  • People who have previously had cancer in the digestive tract or have had bowel surgery
  • People with kidney disease
  • People living with HIV/AIDS or another serious infection
  • People whose pregnancy has been found to involve chromosomal or structural abnormalities in the baby
  • People who have other immune-related conditions, such as multiple sclerosis, rheumatoid arthritis, or primary sclerosing cholangitis
  • People who have taken prebiotic, probiotic, or postbiotic supplements in the month before their first sample collection
  • People who have had a stomach or gut infection during or within one month before their first sample collection
  • People who have travelled outside of Canada or the United States in the month before their first sample collection
  • For the IBD group: pregnant people whose IBD involves active perianal disease (around the anal area) or disease affecting areas outside the intestines

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 7782327016

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 March 2026
Est. completion
1 February 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Correlation between maternal gut microbiota during pregnancy (third trimester) and early postpartum period (2 weeks, 3 months, and 1 year) and infant FCP levels at 3 months and 1 year of age, accounting for maternal adherence to Mediterranean diet.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov